Hsa_circ0021347 as a Potential Target Regulated by B7-H3 in Modulating the Malignant Characteristics of Osteosarcoma

BioMed Research International - United States
doi 10.1155/2019/9301989
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

B7-H3, a Checkpoint Molecule, as a Target for Cancer Immunotherapy

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2020English

B7-H3, a Potential Therapeutic Target, Is Expressed in Diffuse Intrinsic Pontine Glioma

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2012English

B7-H3 as a Promising Target for Cytotoxicity T Cell in Human Cancer Therapy

Oncotarget
Oncology
2016English

The Contrasting Role of B7-H3

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

LncRNA OR3A4 Regulated the Growth of Osteosarcoma Cells by Modulating the miR-1207-5p/G6PD Signaling

OncoTargets and Therapy
OncologyPharmacology
2020English

B7-H3 in Cancer – Beyond Immune Regulation

Trends in Cancer
Cancer ResearchOncology
2018English

Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular Imaging

Cancer Research
Cancer ResearchOncology
2015English

The Immunomodulatory Proteins B7-Dc, B7-H2, and B7-H3 Are Differentially Expressed Across Gestation in the Human Placenta

American Journal of Pathology
Forensic MedicinePathology
2005English

Silencing of B7-H3 Increases Gemcitabine Sensitivity by Promoting Apoptosis in Pancreatic Carcinoma

Oncology Letters
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy